Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The unusually low volume and long intervals between trades indicate that some parties may be expecting news this afternoon. Let's see if something does happen.
There is also the question of punitive damages to discourage just behavior in the future. Whether it works or not would obviously depends on the size of the award..
Doc: You just posted the rest of the story behind ExW's previous misleading post where he cherry-picked the parts that supported the narrative he wanted to push.
Persecution complex accompanied with delusions of grandeur.
Doc,
I was thinking the same. Perhaps the MHRA is extending the MAA timeline to give the company time to get at least some EDEN units in place to be better prepared for demand upon approval. That would mean the MHRA has information from NWBIO about expected Eden timelines - perhaps from RFI queries?
Perhaps the idea was to fob it off onto a snail-paced legal system to make it easier to continue the fraud.
Us NWBO longs would rather fight than quit
Along the way they have also adjusted their strategy and plans to conform to emerging science, standards, and regulatory changes.
Or the Poli Science major either.
I suspect LP will take $20B in license fees over some agreed period of time.😀 Then turn to the next in line.
Remember her use of "franchise".
P.S., a search of clinicaltrials.gov shows 1,454 active Keytruda trials.
Great summary of the wandering goalposts. It also shows up the incongruous claim that management hasn't been doing anything (except enrich themselves) or that they are incompetent. Perfect? No. Incompetent? No.
They have worked against great odds and a well funded army of MMs, HFs and fudsters. Heck, we now have one called Nemesis. What's next? Someone calling themself The Apocalypse?
I agree that his sentences run into one another. He also mentioned the Nature article and perhaps his reference to more in the Fall was about what could follow from that trial. I believe the primary completion of that trial is in August, 2024?
Isn't the 10Q written to reflect events and status as of March 30th, 2024? If so, inspections could have taken place since then to maintain the 150-day timeline for May 19th or soon after that.
More likely waiting for instructions and new FUD points.
A methodical but inexorable advance toward the finish line. The cadence could speed up considerably as more events in that progress appear in the public domain.
Tell your bosses to stop manipulating the stock.
You are referring to Ned?
I guess that the MMs have created, knowingly, a 'too-big-to-fail' scenario and, just like the Financial industry in 2008, are depending on some regulatory rescue or exemption (not sure of the correct term) to avoid massive losses. Given their political connections, at worst, a big fine or perhaps not even that.
Curious as to what updates you expect during this period. The MAA is in and the MHRA is working though its process. Eden has been contracted for the manufacture of the first production candidates. And the company cannot confirm or deny any deal discussions. It seems to me that there isn't anything that NWBO, as a single technology company, however significant and powerful that technology may be, can be communicating until a decision is announced by the MHRA.
Boeing's larger problem, which provides the context for the move to SC, was that it was led by disciples of Jack 'quarterly numbers have to be met' Welch. By some accounts, the corporate culture was drastically different pre- and post- the currently exiting management, with the former being said to be better in that it focused on technical competency and safety.
In support of your post:
As we know, therapies that target some but not all antigens in a tumor, I believe IMUC was one of them, have been tried but have not proven to be effective. IMUC's therapy was not approved, but as someone on this board pointed out, it may have been Flipper, they could have identified the subset for which it did work and then move forward with that subset.
they first would have seen control patients that were eventing later than the treatment arm because the treatment arm was showing false progression - pseudo progression / psPD - due to DCVax-l that couldn't be measured correctly due to the antiquated progression determination criteria). But at the same time, they would have also (likely) seen that progression in the treatment patients was also disappearing with time. The FDA may have also seen from the data that some of the control arm patients that were crossing over were also demonstrating psPD after crossing over, that later went away.
Thank you.
I was talking to the optimists - exuberant or not. You, on the other hand can STFU.
I don't want to step on any toes, but it seems to me that some contributors on this board are prone to bouts of irrational exuberance. Can we just stick to good ole' optimism, bottle the exuberance, and uncork it when it is warranted?
Positioning by Citadel for a defense based on review and comments by oncologists instead of just that of a Stat News 'biotech analyst'? They can always say that these opinions have been provided to them over a while. But then the question would be why did they not bring it up in their earlier filings. 🤔
I have thought that too since this ID emerged - the difference in the legal systems puts this person in greater jeopardy if they are a British citizen.
Some on the board think this is Pyrrh or AF.
You will know followed by a pink slip from your HF/MM employer.
Given an expected binary event - MHRA approval - in the next 30 - 90 days, is there any other mud these slimeballs can sling at DCVAX-L, NWBO, Linda Liau, et al., when positive news breaks?
Fudsters, longs know you all are itching to post all your old arguments - it is grapefruit juice, ATLD-DC is not DCVAX-L, post hoc SAP, PFS failed, NWBO does not have the license from UCLA, etc. So just hold off on that barrage of posts and do not clutter up this board with your repeated and refuted allegations.
Recall Ex's post denying that polyICLC (Hiltonol) was approved for other indications by deliberately misspelling Hiltonol in his search query.
I follow a few other message boards and there is almost none to very little FUDding going on. The decade+ constant bashing on this board and massive spoofing by MMs for a penny stock is very telling. What are they afraid of?
And we know of 7 MMs who are experts at shorting.
There are many still trying to prove that the earth is flat.
"lab rat studies" reminds me of JonDoeUK - he posted a lot of those types of articles to try and push back against DCVAX-L. Whatever happened to him? Or Is he here now as Nemesis18?
LC - you do you, I will stick with Flipper's analysis.
Or, if an RFI is issued, then a CHM is not needed until NWBO's response has been submitted.
Presumably, your sources have connections at KC and can make a recommendation to do that, if KC has not already done so.
BSB, you were absent from this board for quite a while. Just curious, but what prompted you to start posting again?
He thinks he is safe since he is British, or claims to be.